Clinical Trial Update: A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on PF-06954522 in adults with type 2 diabetes mellitus and obesity to assess tolerability and activity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-06954522

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity | Phase 1 | Status: COMPLETED